These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8884064)

  • 1. Receptor assays in the clinical laboratory.
    Soldin SJ
    Clin Biochem; 1996 Oct; 29(5):439-44. PubMed ID: 8884064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus metabolite cross-reactivity in different tacrolimus assays.
    Murthy JN; Davis DL; Yatscoff RW; Soldin SJ
    Clin Biochem; 1998 Nov; 31(8):613-7. PubMed ID: 9876892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophilins in the nervous system.
    Snyder SH; Lai MM; Burnett PE
    Neuron; 1998 Aug; 21(2):283-94. PubMed ID: 9728910
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs.
    Zhang Y; Zhang R
    Drug Test Anal; 2018 Jan; 10(1):81-94. PubMed ID: 28851030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophilin receptors for immunosuppressive drugs.
    Soldin SJ; Murthy JN; Donnelly JG; Chen Y; Goodyear N
    Ther Drug Monit; 1993 Dec; 15(6):468-71. PubMed ID: 7510077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
    McShane AJ; Bunch DR; Wang S
    Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
    DeFrance A; Armbruster D; Petty D; Cooper KC; Dasgupta A
    Ther Drug Monit; 2011 Feb; 33(1):128-31. PubMed ID: 21079546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor (immunophilin-binding) assay for immunosuppressive drugs.
    Soldin SJ
    Ther Drug Monit; 1995 Dec; 17(6):574-6. PubMed ID: 8588223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor assay based on surface plasmon resonance for the assessment of the complex formation activity of cyclosporin A and its metabolites.
    Vollenbroeker B; Fobker M; Specht B; Bartetzko N; Erren M; Spener F; Hohage H
    Int J Clin Pharmacol Ther; 2003 Jun; 41(6):248-60. PubMed ID: 12816177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-center Performance Evaluations of Tacrolimus and Cyclosporine Electrochemiluminescence Immunoassays in the Asia-Pacific Region.
    Qin X; Rui J; Xia Y; Mu H; Song SH; Raja Aziddin RE; Miles G; Sun Y; Chun S
    Ann Lab Med; 2018 Mar; 38(2):85-94. PubMed ID: 29214751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor radioligand system for measuring digoxin activity.
    Manchester EL; Giesbrecht E; Soldin SJ
    Ther Drug Monit; 1987; 9(1):61-6. PubMed ID: 3033851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of tacrolimus (FK 506) and cyclosporin G in whole blood.
    Annesley TM; Hunter BC; Fidler DR; Giacherio DA
    Ther Drug Monit; 1995 Aug; 17(4):361-5. PubMed ID: 7482690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytic performance of two automated nonpretreatment digoxin immunoassays.
    De BK; Booth DD; Magee PJ; Moore ML; Preuss TM; Rose TA; Roberts WL
    Ther Drug Monit; 1999 Feb; 21(1):123-8. PubMed ID: 10051065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
    Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
    Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophilins: their properties and their potential role in therapeutic drug monitoring.
    Soldin SJ
    Ther Drug Monit; 2000 Feb; 22(1):44-6. PubMed ID: 10688257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy evaluation of Roche and Siemens tacrolimus and cyclosporine assays in comparison with liquid chromatography-tandem mass spectrometry.
    Ko DH; Cho EJ; Lee W; Chun S; Min WK
    Scand J Clin Lab Invest; 2018 Oct; 78(6):431-438. PubMed ID: 30270673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring.
    Morris RG
    Ther Drug Monit; 2000 Apr; 22(2):160-2. PubMed ID: 10774626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin.
    Donnelly JG; Soldin SJ
    Transplant Proc; 1991 Dec; 23(6):2886-9. PubMed ID: 1721305
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of CYP3A5 on the metabolism of cyclosporine A and tacrolimus in the evaluation of efficiency and safety of immunosuppressive treatment in patients after kidney transplantation.
    Sienkiewicz B; Hurkacz M; Kuriata-Kordek M; Augustyniak-Bartosik H; Wiela-HojeĊ„ska A; Klinger M
    Pharmazie; 2016 Oct; 71(10):562-565. PubMed ID: 29441922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantoprazole and cyclosporine or tacrolimus.
    Schwrer H; Lorf T; Ringe B; Ramadori G
    Aliment Pharmacol Ther; 2001 Apr; 15(4):561-2. PubMed ID: 11284790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.